Literature DB >> 3595479

Prognosis of perinatal brain damage: a prospective study of a one year birth cohort of 12,000 children.

P Rantakallio, L von Wendt, M Koivu.   

Abstract

The prognosis of perinatal brain damage was studied prospectively in a one year birth cohort of 12,000 children born in Northern Finland in 1966. Children were included in the study if they had an Apgar score of 0 at 1 min or less than 5 at 15 min, convulsions during the neonatal period, or a diagnosis of asphyxia, brain injury or intraventricular haemorrhage, but did not have CNS malformation, chromosomal aberrations or hereditary CNS degeneration. There were 233 children, 19.3 per thousand, of which 134, 58.0% were boys. Eighty-four, 36.4% died during the first 28 days and 7 children died before the age of 14 years, 6 of the latter group being handicapped. There were 44 children, 29.9% who had mental retardation, IQ less than 71, epilepsy or cerebral palsy. With regard to these children 13 had normal school performance, but there were 12 other children in the perinatal brain damage group who needed special education, two of them because of deafness. Perinatal brain damage accounted for 57.5% of all neonatal deaths, 30% of admissions to a special nursery and 12.5% of mental retardation (IQ less than 71), epilepsy and cerebral palsy at the age of 14.

Entities:  

Mesh:

Year:  1987        PMID: 3595479     DOI: 10.1016/0378-3782(87)90040-5

Source DB:  PubMed          Journal:  Early Hum Dev        ISSN: 0378-3782            Impact factor:   2.079


  3 in total

1. 

Authors:  H Schneider
Journal:  Arch Gynecol Obstet       Date:  1995-12       Impact factor: 2.344

Review 2.  Prevention of mental handicaps in children in primary health care.

Authors:  P M Shah
Journal:  Bull World Health Organ       Date:  1991       Impact factor: 9.408

3.  Association of perinatal events, epilepsy, and central nervous system trauma with juvenile delinquency.

Authors:  P Rantakallio; M Koiranen; J Möttönen
Journal:  Arch Dis Child       Date:  1992-12       Impact factor: 3.791

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.